Social Media Tool Kit

Welcome to the Locatim Social Media Tool Kit

To download all the files, please complete the simple form below.

LOCATIM contains Bovine concentrated lactoserum containing specific immunoglobulin G antibodies against E. coli F5 (K99) adhesion ≥2.8* log /ml. Pharmaceutical form: oral solution. Indications for use: Reduction of mortality caused by enterotoxicosis associated with E. coli F5 (K99) adhesin during the first days of life as a supplement to colostrum from the dam. Amounts to be administered and administration route: Oral administration of 60 ml as soon as possible, preferably given within the first 4 hours, but not later than 12 hours after birth. The product should be administered neat or diluted in milk or in milk replacer within the first 12 hours of the calf’s life, preferably, as soon as it is receptive. Contraindications: None. Adverse reactions (frequency and seriousness): None known. Withdrawal period(s): Zero days. Legal categories: IE: POM UK: POM-VPS. Further information available in the SPC or from Forte Healthcare Ltd.

Locatim contains Bovine concentrated lactoserum containing specific immunoglobulin G antibodies against E. coli F5 (K99) adhesion ≥2.8* log /ml. IE: POM; UK: POM-VPS. Further information available from the package leaflet, SPC or from Forte Healthcare Ltd.

* Nussbaum O et al. (2022) Efficacy of the oral administration of specific immunoglobulins against E. coli, rota- and coronavirus for the prevention of neonatal calf diarrhoea in dairy herds. In: World Buiatrics Congress

Welcome to the Locatim Social Media Tool Kit

Head office (Ireland)

Contact us